Perennial Advisors, LLC Ironwood Pharmaceuticals Inc Transaction History

Perennial Advisors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Jul 18, 2019	SELL	$9.8 - $12.89 $175,910 - $231,375	-17,950 Closed	0 $0
Q1 2019 Apr 30, 2019	BUY	$8.27 - $12.73 $148,446 - $228,503	17,950 New	17,950 $243,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Perennial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Perennial Advisors, LLC with notifications on news.